Bp PLC Vertex Pharmaceuticals Inc Transaction History

Bp PLC

  • $13.2 Million
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021
SELL
$181.39 - $202.99 $1.06 Million - $1.19 Million
-5,858 Closed
0 $0
Q2 2021

Aug 09, 2021
SELL
$187.49 - $221.1 $479,411 - $565,352
-2,557 Reduced 30.39%
5,858 $1.18 Million
Q1 2021

May 13, 2021
SELL
$207.02 - $241.31 $397,064 - $462,832
-1,918 Reduced 18.56%
8,415 $1.81 Million
Q4 2020

Feb 08, 2021
SELL
$207.01 - $276.09 $15.3 Million - $20.4 Million
-74,067 Reduced 87.76%
10,333 $2.44 Million
Q3 2020

Oct 30, 2020
BUY
$255.65 - $303.1 $15.1 Million - $17.9 Million
59,100 Added 233.6%
84,400 $22.9 Million
Q2 2020

Aug 05, 2020
SELL
$225.48 - $295.8 $67,644 - $88,740
-300 Reduced 1.17%
25,300 $7.35 Million
Q2 2019

Jul 29, 2019
SELL
$164.61 - $190.37 $230,454 - $266,518
-1,400 Reduced 5.19%
25,600 $4.69 Million
Q4 2018

Feb 06, 2019
SELL
$151.91 - $192.21 $759,550 - $961,050
-5,000 Reduced 15.63%
27,000 $4.47 Million
Q3 2018

Nov 02, 2018
BUY
$167.73 - $192.74 $335,460 - $385,480
2,000 Added 6.67%
32,000 $6.17 Million
Q2 2018

Jul 30, 2018
BUY
$145.72 - $169.96 $145,720 - $169,960
1,000 Added 3.45%
30,000 $5.1 Million
Q4 2017

Feb 06, 2018
SELL
$137.28 - $155.55 $274,560 - $311,100
-2,000 Reduced 6.45%
29,000 $4.35 Million
Q3 2017

Oct 30, 2017
BUY
$148.13 - $162.24 $4.59 Million - $5.03 Million
31,000
31,000 $4.71 Million

Others Institutions Holding VRTX

# of Institutions
1,721
Shares Held
227M
Call Options Held
1.21M
Put Options Held
1.56M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $127B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Bp PLC Portfolio

Follow Bp PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

News

Stay updated on Bp PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email